← Back to Clinical Trials
Recruiting NCT07185178

NCT07185178 Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07185178
Status Recruiting
Phase
Sponsor Istinye University
Condition Asthma-COPD Overlap Syndrome
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-08-04
Primary Completion 2025-08-04

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Video game-based breathing exercisesControl group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-08-04 with a primary completion date of 2025-08-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Asthma and COPD are significant respiratory diseases that can coexist, referred to as Asthma-COPD Overlap Syndrome (ACOS). Patients with ACOS experience more severe clinical outcomes, including rapid decline in lung function, increased symptom burden, and reduced quality of life. Pulmonary rehabilitation-particularly breathing exercises-is a core non-pharmacological intervention recommended for this patient group. In recent years, video game-based applications have emerged as innovative tools that enhance motivation and participation in exercise programs. However, studies investigating the effects of video game-based breathing exercises in ACOS patients are extremely limited. Additionally, although dysfunctional breathing patterns are common in this group, few studies have addressed targeted interventions. The objective of the present study is to evaluate the effects of video game-based breathing exercises on dysfunctional breathing in ACOS patients.

Eligibility Criteria

Inclusion Criteria: * Aged between 40 and 80 years * Diagnosed with Asthma-COPD Overlap Syndrome (ACOS) * Nijmegen Questionnaire score ≥ 23 * No severe asthma * No severe COPD * In a stable condition (no acute exacerbation in the last 4 weeks) * To have the cognitive level suitable to adapt to video games Exclusion Criteria: * Contraindicated for pulmonary rehabilitation * Diagnosed with cancer * Having severe cardiovascular disease * History of thoracic surgery * Presence of acute infectious disease * Cognitive impairment * Presence of vertigo, epilepsy, or visual impairment

Contact & Investigator

Central Contact

HÜSNA GÜZEL, PT,PhD (c)

✉ h.guzel.ftr@gmail.com

📞 +905071194128

Principal Investigator

HÜSNA GÜZEL, PT,PhD (c)

PRINCIPAL INVESTIGATOR

Istinye University

Frequently Asked Questions

Who can join the NCT07185178 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Asthma-COPD Overlap Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07185178 currently recruiting?

Yes, NCT07185178 is actively recruiting participants. Contact the research team at h.guzel.ftr@gmail.com for enrollment information.

Where is the NCT07185178 trial being conducted?

This trial is being conducted at Kocaeli, Turkey (Türkiye).

Who is sponsoring the NCT07185178 clinical trial?

NCT07185178 is sponsored by Istinye University. The principal investigator is HÜSNA GÜZEL, PT,PhD (c) at Istinye University. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology